At early stages of tumorigenesis, TGFβ signaling pathway have tumor-suppressive activity because TGFβ functions as an anti-mitogen, that blocks cell cycle progression at G1 phase, preventing RB hyper-phosphorylation and S phase entry [39]. This evidence concerns the gene RB1 and neoplasm.